icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
Real-world effectiveness of Ledipasvir/Sofosbuvir 8 weeks chronic HCV treatment
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Peter Buggisch1, Karsten Wursthorn1, Petar Atanasov2, Aline Gauthier2, Joerg Petersen1
1IFI Institut für Interdisziplinäre Medizin, Asklepios Klinik St. Georg Haus L, Lohmühlenstr. 5, 20099 , Hamburg, Germany, 2Amaris, London, United Kingdom

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif

Reference
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003850/WC500177995.pdf